FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004109623> ?p ?o ?g. }

• W2004109623 endingPage "899" @default.
• W2004109623 startingPage "894" @default.
• W2004109623 abstract "The aim of this study is to define the maximum tolerated dose (MTD), safety, pharmacokinetics (PKs) and efficacy of ispinesib (SB-715992) in combination with docetaxel. Patients with advanced solid tumours were treated with ispinesib (6-12 mg m(-2)) and docetaxel (50-75 mg m(-2)). Docetaxel was administered over 1 h followed by a 1-h infusion of ispinesib on day 1 of a 21-day schedule. At least three patients were treated at each dose level. Blood samples were collected during cycle 1 for PK analysis. Clinical response assessments were performed every two cycles using RECIST guidelines. Twenty-four patients were treated at four dose levels. Prolonged neutropaenia and febrile neutropaenia were dose limiting in six and two patients, respectively. The MTD was ispinesib 10 mg m(-2) with docetaxel 60 mg m(-2). Pharmacokinetic assessment demonstrated concentrations of ispinesib and docetaxel, consistent with published data from single agent studies of the drugs. Seven patients (six hormone refractory prostate cancer (HRPC), one renal cancer) had a best response of stable disease (>or=18 weeks). One patient with HRPC had a confirmed >50% prostatic-specific antigen decrease. The MTD for ispinesib and docetaxel was defined and the combination demonstrated an acceptable toxicity profile. Preliminary PK data suggest no interaction between ispinesib and docetaxel." @default.
• W2004109623 created "2016-06-24" @default.
• W2004109623 creator A5013291304 @default.
• W2004109623 creator A5013567386 @default.
• W2004109623 creator A5013897432 @default.
• W2004109623 creator A5025296466 @default.
• W2004109623 creator A5030668475 @default.
• W2004109623 creator A5043913115 @default.
• W2004109623 creator A5047003355 @default.
• W2004109623 creator A5051430596 @default.
• W2004109623 creator A5062742458 @default.
• W2004109623 creator A5063597274 @default.
• W2004109623 creator A5068550336 @default.
• W2004109623 creator A5072378199 @default.
• W2004109623 creator A5079408772 @default.
• W2004109623 creator A5023488280 @default.
• W2004109623 date "2008-03-01" @default.
• W2004109623 modified "2023-10-18" @default.
• W2004109623 title "A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours" @default.
• W2004109623 cites W1839238860 @default.
• W2004109623 cites W1841504999 @default.
• W2004109623 cites W1954015558 @default.
• W2004109623 cites W1988678729 @default.
• W2004109623 cites W1998276910 @default.
• W2004109623 cites W2005807653 @default.
• W2004109623 cites W2029178312 @default.
• W2004109623 cites W2037015930 @default.
• W2004109623 cites W2048182747 @default.
• W2004109623 cites W2080849052 @default.
• W2004109623 cites W2108376231 @default.
• W2004109623 cites W2120292596 @default.
• W2004109623 cites W2127405377 @default.
• W2004109623 cites W2130652363 @default.
• W2004109623 cites W2136643719 @default.
• W2004109623 cites W2139248078 @default.
• W2004109623 cites W2141056749 @default.
• W2004109623 cites W2155679349 @default.
• W2004109623 cites W2160059044 @default.
• W2004109623 cites W2163978496 @default.
• W2004109623 cites W2260279612 @default.
• W2004109623 cites W2532474449 @default.
• W2004109623 cites W2898898146 @default.
• W2004109623 cites W4250098813 @default.
• W2004109623 doi "https://doi.org/10.1038/sj.bjc.6604264" @default.
• W2004109623 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2266864" @default.
• W2004109623 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18319713" @default.
• W2004109623 hasPublicationYear "2008" @default.
• W2004109623 type Work @default.
• W2004109623 sameAs 2004109623 @default.
• W2004109623 citedByCount "66" @default.
• W2004109623 countsByYear W20041096232012 @default.
• W2004109623 countsByYear W20041096232013 @default.
• W2004109623 countsByYear W20041096232014 @default.
• W2004109623 countsByYear W20041096232015 @default.
• W2004109623 countsByYear W20041096232016 @default.
• W2004109623 countsByYear W20041096232017 @default.
• W2004109623 countsByYear W20041096232018 @default.
• W2004109623 countsByYear W20041096232019 @default.
• W2004109623 countsByYear W20041096232020 @default.
• W2004109623 countsByYear W20041096232021 @default.
• W2004109623 countsByYear W20041096232022 @default.
• W2004109623 countsByYear W20041096232023 @default.
• W2004109623 crossrefType "journal-article" @default.
• W2004109623 hasAuthorship W2004109623A5013291304 @default.
• W2004109623 hasAuthorship W2004109623A5013567386 @default.
• W2004109623 hasAuthorship W2004109623A5013897432 @default.
• W2004109623 hasAuthorship W2004109623A5023488280 @default.
• W2004109623 hasAuthorship W2004109623A5025296466 @default.
• W2004109623 hasAuthorship W2004109623A5030668475 @default.
• W2004109623 hasAuthorship W2004109623A5043913115 @default.
• W2004109623 hasAuthorship W2004109623A5047003355 @default.
• W2004109623 hasAuthorship W2004109623A5051430596 @default.
• W2004109623 hasAuthorship W2004109623A5062742458 @default.
• W2004109623 hasAuthorship W2004109623A5063597274 @default.
• W2004109623 hasAuthorship W2004109623A5068550336 @default.
• W2004109623 hasAuthorship W2004109623A5072378199 @default.
• W2004109623 hasAuthorship W2004109623A5079408772 @default.
• W2004109623 hasBestOaLocation W20041096231 @default.
• W2004109623 hasConcept C112705442 @default.
• W2004109623 hasConcept C121608353 @default.
• W2004109623 hasConcept C126322002 @default.
• W2004109623 hasConcept C126894567 @default.
• W2004109623 hasConcept C143998085 @default.
• W2004109623 hasConcept C2776694085 @default.
• W2004109623 hasConcept C2777334693 @default.
• W2004109623 hasConcept C2778822529 @default.
• W2004109623 hasConcept C2779984678 @default.
• W2004109623 hasConcept C2780192828 @default.
• W2004109623 hasConcept C2781190966 @default.
• W2004109623 hasConcept C29730261 @default.
• W2004109623 hasConcept C71924100 @default.
• W2004109623 hasConcept C90924648 @default.
• W2004109623 hasConcept C98274493 @default.
• W2004109623 hasConceptScore W2004109623C112705442 @default.
• W2004109623 hasConceptScore W2004109623C121608353 @default.
• W2004109623 hasConceptScore W2004109623C126322002 @default.
• W2004109623 hasConceptScore W2004109623C126894567 @default.
• W2004109623 hasConceptScore W2004109623C143998085 @default.

• next